RNS Number : 7151C
Futura Medical PLC
18 November 2009
|
For immediate release
|
18 November 2009
|
Futura Medical plc
("Futura" or "the Group" or "the Company")
Notification of major interest in shares
|
1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:
|
Futura Medical plc
|
|
2. Reason for the notification
|
|
|
An acquisition or disposal of voting rights
|
Yes
|
|
3. Full name of person(s) subject to the notification obligation:
|
Brookwell Limited
|
|
4. Full name of shareholder(s) (if different from 3.):
|
Nortrust Nominees Limited
|
|
5. Date of the transaction and date on which the threshold is crossed or reached:
|
18 November 2009
|
|
6. Date on which issuer notified:
|
18 November 2009
|
|
7. Threshold(s) that is/are crossed or reached:
|
5%
|
|
A: Voting rights attached to shares
|
|
Class/type of shares
if possible using the ISIN CODE
|
Situation previous to the Triggering transaction
|
Resulting situation after the triggering transaction
|
|
Number of Shares
|
Number of Voting Rights
|
Number of shares Direct
|
Number of voting rights
|
% of voting rights
|
|
Direct
|
Indirect
|
Direct
|
Indirect
|
|
Ordinary Shares
GB0033278473
|
3,233,835
|
3,233,835
|
3,233,835
|
4.79%
|
|
4.79%
|
|
|
B: Financial Instruments
|
|
Resulting situation after the triggering transaction
|
|
Type of financial instrument
|
Expiration date
|
Exercise/ Conversion Period/ Date
|
Number of voting rights that may be acquired if the instrument is exercised/ converted
|
% of voting rights
|
|
None
|
|
|
|
|
|
C: Financial Instruments with similar economic effect to Qualifying Financial Instruments
|
|
Resulting situation after the triggering transaction
|
|
Type of financial
instrument
|
Exercise price
|
Expiration date
|
Number of voting rights instrument refers to
|
% of voting rights
|
|
None
|
|
|
|
|
|
Total (A+B+C)
|
|
Number of voting rights
|
% of voting rights
|
|
3,233,835
|
4.79%
|
|
9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable:
|
|
None
|
|
Proxy Voting:
|
|
10. Name of the proxy holder:
|
N/A
|
|
11. Number of voting rights proxy holder will cease to hold:
|
N/A
|
|
12. Date on which proxy holder will cease to hold voting rights:
|
N/A
|
|
13. Additional information:
|
Progressive AIM Realisation Limited is Investment Manager to Brookwell Limited
|
|
14. Contact name:
|
Russell Scott
|
|
15. Contact telephone number:
|
020 7490 4355
|
For further information:
|
Futura Medical plc
|
|
|
James Barder, Chief Executive
|
Tel: +44 (0) 1483 685 670
|
|
|
|
|
mail to: james.barder@futuramedical.co.uk
|
www.futuramedical.co.uk
|
|
|
|
|
Nomura Code Securities Limited
|
|
|
Charles Walker / Giles Balleny
|
Tel: +44 (0) 20 7776 1200
|
|
|
|
|
For media enquiries please contact:
|
|
|
|
|
|
Buchanan Communications
|
|
|
Mark Court / Jennie Spivey / Stasa Filiplic
|
Tel: +44 (0) 20 7466 5000
|
|
|
|
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLEASFPFEDNFFE